Tranexamic Acid
Tranexamic acid is a medication used primarily for its antifibrinolytic properties, which means it helps prevent the breakdown of blood clots.tranexamic acid is effective in various scenarios where controlling or reducing bleeding is crucial. Its primary mechanism is the inhibition of fibrinolysis by blocking the activation of plasminogen, thereby enhancing clot stability and reducing bleeding.
We are Synchemia Research Chemical specializes in supply of Tranexamic acid impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities and Nitrosamine. Tranexamic acid is a medication used primarily for its antifibrinolytic properties, which means it helps prevent the breakdown of blood clots is a medication used primarily for its antifibrinolytic properties, which means it helps prevent the breakdown of blood clots. we the Synchemia are ensuring the purity and quality of its impurities which is crucial for pharmaceutical API manufacturing companies for regulatory compliance. If you have any specific questions about Tranexamic acid impurities or related topics, feel free to ask!
Pharmaceutical Reference Standards
| CAT No | SRC-T20001 |
| CAS No | 1197-18-8 |
| Mol.F. | C8H15NO2 |
| Mol.Wt. | 157.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20002 |
| CAS No | 93940-19-3 |
| Mol.F. | C16H27NO4 |
| Mol.Wt. | 297.4 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-T20003 |
| CAS No | 1197-17-7 |
| Mol.F. | C8H15NO2 |
| Mol.Wt. | 157.2 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-T20004 |
| CAS No | 1803601-44-6 |
| Mol.F. | C8H13NO2 : HCl |
| Mol.Wt. | 155.2 : 36.5 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-T20005 |
| CAS No | 56-91-7 |
| Mol.F. | C8H9NO2 |
| Mol.Wt. | 151.2 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-T20006 |
| CAS No | 82755-59-7 |
| Mol.F. | C16H28N2O3 |
| Mol.Wt. | 296.4 |
| INV STATUS | IN STOCK |
| CAT No | SRC-T20007 |
| CAS No | 1599413-49-6 |
| Mol.F. | C9H15NO3 |
| Mol.Wt. | 185.2 |
| INV STATUS | IN STOCK |
| CAT No | SRC-T20008 |
| CAS No | NA |
| Mol.F. | C24H41N3O4 |
| Mol.Wt. | 435.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20009 |
| CAS No | NA |
| Mol.F. | C24H41N3O4 |
| Mol.Wt. | 435.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20010 |
| CAS No | 50738-63-1 |
| Mol.F. | C9H17NO2 |
| Mol.Wt. | 171.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20011 |
| CAS No | 330838-52-3 |
| Mol.F. | C8H13NO2 |
| Mol.Wt. | 155.2 g/mol |
| INV STATUS | IN STOCK |
| CAT No | SRC-T20012 |
| CAS No | 137384-55-5 |
| Mol.F. | C8H15BrO |
| Mol.Wt. | 207.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20013 |
| CAS No | 1292837-95-6 |
| Mol.F. | C613C2H1515NO2 |
| Mol.Wt. | 160.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20014 |
| CAS No | NA |
| Mol.F. | C213C6H15NO2 |
| Mol.Wt. | 163.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-T20015 |
| CAS No | 2714435-89-7 |
| Mol.F. | C8H13D2NO2 |
| Mol.Wt. | 159.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.